Israeli business newspaper Globes is reporting that the U.S. Department of Veterans Affairs has signed an agreement with Brainsway, a Jerusalem company profiled by us many times before, to trial the firm’s deep transcranial magnetic stimulation (TMS) device on twenty patients with attention deficit disorder. Experts believe that TMS technology might become increasingly useful as a new way to treat a variety of psychiatric and neurological problems, such as bipolar disorder, cocaine or nicotine addiction, or even as a treatment for symptoms of Parkinson’s and multiple sclerosis.
More about the upcoming trial from Globes…
Flashbacks: Brainsway to Test TMS for Smoking Cessation; Magnetic Brain Stimulation for Cocaine Addiction, Multiple Sclerosis?; Neuronetics TMS Depression Therapy Gets FDA OK; Experiencing Transcranial Magnetic Stimulation; Positive Results Reported for Deep TMS H System For Depression; Deep TMS Technology by Brainsway
VA to Trial Transcranial Magnetic Stimulation for ADD
August 7th, 2009 
Medgadget Editors Psychiatry